Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8438)
All Articles published online
|
Publishing Process of This Article
|
Nov 18, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Enomoto H, Nishiguchi S. Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C. World J Hepatol 2015; 7(26): 2681-2687 [PMID: 26609345 DOI: 10.4254/wjh.v7.i26.2681] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i26/2681.htm |
| Number | Citing Articles |
| 1 |
Beatriz Suarez, Laura Prats-Mari, Juan P. Unfried, Puri Fortes. LncRNAs in the Type I Interferon Antiviral Response. International Journal of Molecular Sciences 2020; 21(17): 6447 doi: 10.3390/ijms21176447
|
| 2 |
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses. World Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
|
| 3 |
Daniel Melendez-Mena, Miguel Angel Mendoza-Torres, Virginia Sedeño-Monge, Víctor Hugo García y García, Elain Rivera-García, Laura Sánchez-Reza, María del Carmen Baxin Domínguez, Belinda Guzmán-Flores, Ygnacio Martinez-Laguna, José Manuel Coronel Espinoza, Iván Galindo-Santiago, Juan Carlos Flores-Alonso, Verónica Vallejo-Ruiz, Paulina Cortes-Hernandez, Julio Reyes-Leyva, Francisca Sosa-Jurado, Gerardo Santos-López. Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy. PeerJ 2021; 9: e12051 doi: 10.7717/peerj.12051
|
| 4 |
Hany S. Bedair, Brian M. Schurko, Maureen K. Dwyer, David Novikov, Afshin A. Anoushiravani, Ran Schwarzkopf. Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint Infection. The Journal of Arthroplasty 2019; 34(1): 132 doi: 10.1016/j.arth.2018.09.036
|
| 5 |
Thomas Blank, Marco Prinz. Type I interferon pathway in CNS homeostasis and neurological disorders. Glia 2017; 65(9): 1397 doi: 10.1002/glia.23154
|
| 6 |
Bingxin Lei, Hongxiao Song, Fengchao Xu, Qi Wei, Fei Wang, Guangyun Tan, Haichun Ma. When does hepatitis B virus meet long-stranded noncoding RNAs?. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.962186
|
| 7 |
Camelia Sultana, Gabriela Oprişan, Monica Delia Teleman, Sorin Dinu, Cristiana Oprea, Mihai Voiculescu, Simona Ruta. Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C. World Journal of Gastroenterology 2016; 22(37): 8406-8413 doi: 10.3748/wjg.v22.i37.8406
|
| 8 |
Kiran Iqbal Masood, Maliha Yameen, Javeria Ashraf, Saba Shahid, Syed Faisal Mahmood, Asghar Nasir, Nosheen Nasir, Bushra Jamil, Najia Karim Ghanchi, Iffat Khanum, Safina Abdul Razzak, Akbar Kanji, Rabia Hussain, Martin E. Rottenberg, Zahra Hasan. Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02489-4
|
| 9 |
Armstrong Murira, Alain Lamarre. Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection. Frontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00609
|
| 10 |
Adrian Keogh, Sevil Şenkardeş, Jeffrey Idle, Ş. Küçükgüzel, Diren Beyoğlu. A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells. Metabolites 2017; 7(2): 23 doi: 10.3390/metabo7020023
|
| 11 |
Jun Inoue, Atsushi Kanno, Yuta Wakui, Masahito Miura, Tomoo Kobayashi, Tatsuki Morosawa, Takayuki Kogure, Eiji Kakazu, Masashi Ninomiya, Yasuyuki Fujisaka, Teruyuki Umetsu, Satoshi Takai, Takuya Nakamura, Tooru Shimosegawa. Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment. The Tohoku Journal of Experimental Medicine 2017; 241(1): 21 doi: 10.1620/tjem.241.21
|
| 12 |
Jae-Won Lee, Won Kim, Eun-Kyung Kwon, Yuri Kim, Hyun Mu Shin, Dong-Hyun Kim, Chan-Ki Min, Ji-Yeob Choi, Won-Woo Lee, Myung-Sik Choi, Byeong Gwan Kim, Nam-Hyuk Cho, Eui-Cheol Shin. Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C. PLOS ONE 2017; 12(6): e0179094 doi: 10.1371/journal.pone.0179094
|